looksthread
Pharmaceutical
PharmaceuticalSkin

Topical Cosmetic Peptides

Also known as Matrixyl, palmitoyl pentapeptide-4, Argireline, acetyl hexapeptide-8, signal peptides

The peptides you can actually buy in a shop. Mild, safe, and consistently oversold.

Evidence
Weak
Typical cost
$20 – $90
Permanence
Ongoing use
Timeline
Any measurable change over 12 weeks or more.

$20–90 per product.

How it works

Signal peptides such as palmitoyl pentapeptide-4 (Matrixyl) mimic fragments of collagen breakdown, nudging fibroblasts to produce more matrix. Neurotransmitter-inhibiting peptides such as acetyl hexapeptide-8 (Argireline) interfere with SNARE-complex vesicle docking — a very distant, very weak topical echo of what botulinum toxin does at the neuromuscular junction.

How it's used

Used in serums and moisturisers at low concentrations, morning or night, layered under sunscreen. Reasonable as a supporting act; not a substitute for a retinoid or sunscreen.

Trade-offs

In favour

  • Extremely well tolerated
  • No systemic exposure worth discussing
  • Safe in pregnancy, unlike retinoids
  • Pleasant to use and easy to add to a routine

Against

  • Effect sizes are small and often within measurement noise
  • Argireline is marketed as "topical Botox", which it is not — the peptide barely penetrates to where it would need to act
  • Trials are frequently manufacturer-funded
  • Expensive for the benefit

Risks and side effects

Read before deciding
  • Occasional contact irritation
  • The main risk is opportunity cost — money and routine slots that a retinoid or sunscreen would use better

How good is the evidence?

Weak
Limited or conflicting evidence.

Some small, often industry-funded trials show modest improvements. Effects are far smaller than retinoids and the marketing language is not supported.

Sources

Sources point to guideline bodies and literature searches rather than single papers, so they stay accurate as the evidence moves.

Discuss this in the forum

Open threads

More in Pharmaceutical